ERBB2 and triple-negative breast carcinoma: MDA-MB-231 cells are used extensively as a model for triple-negative breast cancer, based on the lack of expression of cell surface receptors, estrogen receptor (ER), progesterone receptor (PR) and the growth factor receptor, human epidermal growth factor receptor-2 (HER2/ERBB2) [4].